Yokota Tomoya

ヨコタトモヤ | Yokota Tomoya

Affiliation and department：

Research field (1)： Tumor diagnostics and therapeutics

Research keywords (1)： head and neck cancer

Research theme for competitive and other funds (1)：

2022 - 2025 Induction chemotherapy with docetaxel plus cisplatin and 5-fluorouracil aiming at minimally invasive surgery without adjuvant radiotherapy for human papillomavirus-associated oropharyngeal cancers

Papers (195)：

清水康, 高橋俊二, 折舘伸彦, 田中薫, 藤本保志, 松本光史, 横田知哉, 山崎知子, 高橋雅信, 上田勉, et al. First-Line Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: 5-Year Update of the Japanese Subgroup of KEYNOTE-048(タイトル和訳中). 日本癌治療学会学術集会抄録集. 2023. 61回. FR5-2
門脇重憲, 岡弘毅, 長島健悟, 西秀昭, 熊井良彦, 飯島宏章, 大上研二, 清水康, 加納里志, 伊東和恵, et al. 白金製剤・ニボルマブ不応・不耐後の再発・転移頭頸部扁平上皮癌の臨床転帰に関する後方視的多施設共同研究. 頭頸部癌. 2023. 49. 2. 137-137
門脇重憲, 岡弘毅, 長島健悟, 西秀昭, 熊井良彦, 飯島宏章, 大上研二, 清水康, 加納里志, 伊東和恵, et al. 白金製剤・ニボルマブ不応・不耐後の再発・転移頭頸部扁平上皮癌の臨床転帰に関する後方視的多施設共同研究. 頭頸部癌. 2023. 49. 2. 137-137
Tomoya Yokota, Hiroki Yukino, Mihoko Doi, Hisatsugu Ohori. Real-world experience of tropomyosin receptor kinase inhibition with entrectinib in ETV6-NTRK3 positive metastatic salivary secretory carcinoma: A case series. Head & Neck. 2023
川口大貴, 川上武志, 津軽開, 西村在, 伏木邦博, 大嶋琴絵, 對馬隆浩, 戸高明子, 濱内諭, 横田知哉, et al. 実臨床における化学療法+Nivolumab併用療法の有効性と安全性に関する検討. 日本消化器病学会雑誌. 2023. 120. 臨増総会. A313-A313

ｍore...

MISC (64)：

太田陽介, 古平毅, 藤井博文, 下川元継, 中島寅彦, 門田伸也, 横田知哉, 本間明宏, 上田眞也, 秋元哲夫. 日本人の頭頸部扁平上皮癌患者に対するCetuximab併用放射線治療の観察研究(JROSG12-2) 有害事象に関する中間評価. 頭頸部癌. 2019. 45. 3. 330-336
Barbara Burtness, Robert I. Haddad, Jose Dinis, Jose Manuel Trigo Perez, Tomoya Yokota, Luciano De Souza Viana, Ilya Romanov, Jan Baptist Vermorken, Jean Bourhis, Makoto Tahara, et al. LUX-head and neck 2: Randomized, double-blind, placebo-controlled, phase III trial of afatinib as adjuvant therapy after chemoradiation (CRT) in primary unresected, high/intermediate-risk, squamous cell cancer of the head and neck (HNSCC) patients (pts). JOURNAL OF CLINICAL ONCOLOGY. 2017. 35
長岡真人, 鬼塚哲郎, 横田知哉, 濱内諭, 飯田善幸, 上條朋之, 木谷卓史. 当院でレンバチニブを使用した甲状腺癌17例の検討. 日本耳鼻咽喉科学会会報. 2017. 120. 4. 646-646
Katsuyuki Murai, Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi, Keiji Sugiyama, Takahiro Tsushima, Seiichiro Mitani, Akiko Todaka, Kazunori Honda, Tomoya Yokota, et al. Efficacy of bevacizumab in combination with doublet chemotherapy as first-line therapy in metastatic colorectal cancer according to KRAS status. JOURNAL OF CLINICAL ONCOLOGY. 2017. 35. 4
野村基雄, 安藤正志, 横田知哉, 宮崎拓也. 根治切除不能・転移性粘膜黒色腫に対するニボルマブの第II相試験(Trial in progress). 日本癌治療学会学術集会抄録集. 2016. 54回. P24-4

ｍore...

Books (2)：

レファレンス頭頸部癌診療困ったときの考え方
日本医事新報社 2021 ISBN:9784784959808
臨床頭頸部癌学

Lectures and oral presentations (1)：

head and neck

Education (2)：

2000 - 2004 京都府立医科大学大学院医学研究科
1992 - 1998 Kyoto Prefectural University of Medicine

Work history (5)：

2013/04 - 現在 Shizuoka Cancer Center Division of Gastrointestinal Oncology
2004/07 - 現在京都府立医科大学大学院医学研究科研修員
2011/04 - 2013/03 Shizuoka Cancer Center Division of Gastrointestinal Oncology
2008/01 - 2011/03 Aichi Cancer Center Department of Clinical Oncology
2005/01 - 2007/12 University of Texas, MD Anderson Cancer Center Department of Experimental Radiation Oncology Postdoctoral fellow

Committee career (2)：

Pharmaceuticals and Medical Devices Agency Expert advisor
国立研究開発法人日本医療研究開発機構課題評価委員、科学技術調査員

Awards (3)：

2005 - The University of Texas M.D. Anderson Cancer Center Odyssey Fellow, the Kimberly Clark Foundation Award for Scientific Achievement at The University of Texas M.D. Anderson Cancer Center
2005 - Mochida Memorial Foundation for Medical and Pharmaceutical Research Mochida Memorial Foundation for Medical and Pharmaceutical Research
2004 - The Yasuda Medical Foundation The Yasuda Medical Foundation

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page